Stanford Medicine’s new proton therapy facility is ready for patients. On June 4 a child with a rare brain tumor became the first to receive treatment.
Stanford Medicine’s Health Compass podcast brings the latest medical research to life through compelling stories that connect with your everyday health experiences.
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.
In the new Stanford Medicine issue, we traverse the path of research from aha moments to medical innovations — and meet some of the people driving discovery.
Given together, two medications unexpectedly improved the clearance of mucus from the lungs of animals. Stanford Medicine researchers will test them in people.
Immune cells engineered to sense metabolic byproducts secreted by cancer cells ‘follow their noses’ to migrate to and infiltrate solid tumors in mice.
A trial co-led by Stanford Medicine researchers found that a new drug, obexelimab, can be used to effectively treat patients with the rare immune condition known as IgG4-related disease.
Stanford Medicine researchers have found a critical link between bacteria living in the gut and aging-related cognitive decline.
